DLB · NYSE · CIK 0001308547

Dolby Laboratories, Inc.

Dolby Laboratories, Inc.’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G filed on Oct 27, 2026. In fiscal 2025 (year ended Sep 26, 2025) it reported revenue of $1.3B and net income of $255.0M, according to its XBRL data on EDGAR. Its EDGAR record lists 46 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.3B
Net income, FY2025
$255.0M
Form 4 filings on record, past 12 months
46

Company overview

Legal name (as filed)
Dolby Laboratories, Inc.
Ticker
DLB
SEC Central Index Key (CIK)
0001308547
Industry (SIC)
Patent Owners & Lessors (code 6794)
Business address
SAN FRANCISCO, CA
State or country of incorporation
DE
Fiscal year ends
September 27
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1207 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Dolby Laboratories, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.3BFY2021$1.3BFY2022$1.3BFY2023$1.3BFY2024$1.3BFY2025
Net income
$310.2MFY2021$184.1MFY2022$200.7MFY2023$261.8MFY2024$255.0MFY2025
DLB annual results
ItemFY2021
ended Sep 24, 2021
FY2022
ended Sep 30, 2022
FY2023
ended Sep 29, 2023
FY2024
ended Sep 27, 2024
FY2025
ended Sep 26, 2025
Revenue$1.3B$1.3B$1.3B$1.3B$1.3B
Net income$310.2M$184.1M$200.7M$261.8M$255.0M
Diluted EPS$2.97$1.81$2.05$2.69$2.62
Total assets$3.1B$2.7B$3.0B$3.1B$3.2B
Cash and equivalents$1.2B$620.1M$745.4M$482.0M$701.9M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

DLB latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Nov 18, 202510-KAnnual report· period Sep 26, 2025Document · Index
Jul 30, 202610-QQuarterly report· period Jun 26, 2026Document · Index
Aug 27, 20268-KDirector or officer change; Regulation FD disclosure; Other events· period Aug 25, 2026Document · Index
Dec 16, 2025DEF 14ADefinitive proxy statement· period Feb 3, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Dolby Laboratories, Inc., by form type:

4 ×18144 ×12SCHEDULE 13G/A ×38-K ×23 ×1SCHEDULE 13G ×1S-8 ×110-Q ×1SD ×1
DLB recent filings
FiledFormWhat it isOriginal
Oct 27, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Oct 22, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Oct 5, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 2, 2026Document · Index
Oct 1, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Sep 11, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Sep 1, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 28, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 28, 2026Document · Index
Aug 28, 20263Initial statement of beneficial ownership· period Aug 27, 2026Document · Index
Aug 27, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 25, 2026Document · Index
Aug 27, 20268-KDirector or officer change; Regulation FD disclosure; Other events· period Aug 25, 2026Document · Index
Aug 25, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Aug 14, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 10, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 5, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026Document · Index
Aug 3, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 30, 202610-QQuarterly report· period Jun 26, 2026Document · Index
Jul 30, 20268-KResults of operations; Other events· period Jul 30, 2026Document · Index
Jul 6, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jul 1, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 4, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
Jun 1, 2026144Notice of proposed sale of securitiesDocument · Index
May 29, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 27, 20264Statement of changes in beneficial ownership (insider trade)· period May 22, 2026Document · Index
May 22, 2026144Notice of proposed sale of securitiesDocument · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 15, 2026144Notice of proposed sale of securitiesDocument · Index
May 14, 20264Statement of changes in beneficial ownership (insider trade)· period May 12, 2026Document · Index
May 12, 2026144Notice of proposed sale of securitiesDocument · Index
May 11, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 6, 20264Statement of changes in beneficial ownership (insider trade)· period May 4, 2026Document · Index
May 5, 2026144Notice of proposed sale of securitiesDocument · Index

Insider filing activity

46 Form 4 filings appear in Dolby Laboratories, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Patent Owners & Lessors

All 3 companies in Patent Owners & Lessors· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001308547 and XBRL company facts. Dolby Laboratories, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.